Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim

Clin Mol Hepatol. 2024;30(suppl):s5-s105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

View: 445 Download: 77

Guideline

KASL clinical practice guidelines for management of autoimmune hepatitis 2022

Clin Mol Hepatol. 2023;29(3):542-592. Published online May 3, 2023

DOI: https://doi.org/10.3350/cmh.2023.0087

View: 4536 Download: 333 Web of Science: 3 Crossref: 5

Editorial

Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan

San-Chi Chen

Clin Mol Hepatol. 2023;29(2):352-354. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0101

View: 2995 Download: 66

Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Do Young Kim

Clin Mol Hepatol. 2023;29(2):335-338. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0107

View: 3093 Download: 55

Guideline

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clin Mol Hepatol. 2022;28(4):583-705. Published online October 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0294

View: 14795 Download: 764 Web of Science: 119 Crossref: 133

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2022;28(2):276-331. Published online April 1, 2022

DOI: https://doi.org/10.3350/cmh.2022.0084 Correction in: Clin Mol Hepatol 2022;28(4):940

View: 11611 Download: 616 Web of Science: 47 Crossref: 55

Review

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 15379 Download: 1,456 Web of Science: 66 Crossref: 66

KASL clinical practice guidelines for management of chronic hepatitis B

Clin Mol Hepatol. 2019;25(2):93-159. Published online June 12, 2019

DOI: https://doi.org/10.3350/cmh.2019.1002

View: 25575 Download: 653 Web of Science: 167 Crossref: 151

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

Clin Mol Hepatol. 2018;24(3):169-229. Published online August 10, 2018

DOI: https://doi.org/10.3350/cmh.2018.1004

View: 15030 Download: 226 Web of Science: 20 Crossref: 27

Prevention of Hepatitis B reactivation in the setting of immunosuppression

Venessa Pattullo

Clin Mol Hepatol. 2016;22(2):219-237. Published online June 13, 2016

DOI: https://doi.org/10.3350/cmh.2016.0024

View: 17344 Download: 662 Web of Science: 87 Crossref: 90

KASL clinical practice guidelines: management of hepatitis C

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2016;22(1):76-139. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.76

View: 26828 Download: 209 Web of Science: 64 Crossref: 54

KASL clinical practice guidelines: management of chronic hepatitis B

Clin Mol Hepatol. 2016;22(1):18-75. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.18

View: 25283 Download: 262 Web of Science: 155 Crossref: 136

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(4):325-348. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.325

View: 14091 Download: 164 Crossref: 95

KASL Clinical Practice Guidelines: Management of Alcoholic Liver Disease

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2013;19(3):216-254. Published online September 30, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.3.216

View: 22167 Download: 164 Crossref: 30

Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions

Jae Young Jang, Moon Young Kim, Soung Won Jeong, Tae Yeob Kim, Seung Up Kim, Sae Hwan Lee, Ki Tae Suk, Soo Young Park, Hyun Young Woo, Sang Gyune Kim, Jeong Heo, Soon Koo Baik, Hong Soo Kim, Won Young Tak

Clin Mol Hepatol. 2013;19(1):1-16. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.1

View: 17140 Download: 330 Crossref: 60

KASL Clinical Practice Guidelines: Management of chronic hepatitis B

The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2012;18(2):109-162. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.109

View: 15729 Download: 109 Crossref: 120

11

Special Contribution : Practice guidelines for management of hepatocellular carcinoma 2009

Korean Liver Cancer Study Group and National Cancer Center, Korea

Clin Mol Hepatol. 2009;15(3):391-423. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.391

View: 9583 Download: 106 Crossref: 206

1 |

Viewed By 4951	MAFLD: How is it different from NAFLD?
Viewed By 4830	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4740	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4455	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4412	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 95	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search